Trials / Conditions / Post-ET Myelofibrosis
Post-ET Myelofibrosis
3 registered clinical trials studyying Post-ET Myelofibrosis — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Subop NCT06479135 | Kartos Therapeutics, Inc. | Phase 3 |
| Recruiting | Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a NCT05280509 | Telios Pharma, Inc. | Phase 1 / Phase 2 |
| Unknown | KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intoleran NCT04640532 | Kartos Therapeutics, Inc. | Phase 1 / Phase 2 |